# CORRESP — Ernexa Therapeutics Inc.  (ERNA, ERNAW)  (CIK 0000748592)

> <strong>Ernexa Therapeutics Inc.  (ERNA, ERNAW)  (CIK 0000748592) → SEC staff</strong> · filed 2026-03-26 · ticker ERNA, ERNAW · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-26-012941
- **Form:** CORRESP
- **Filer:** Ernexa Therapeutics Inc.  (ERNA, ERNAW)  (CIK 0000748592)
- **CIK:** 0000748592
- **Ticker:** ERNA, ERNAW
- **Filed:** 2026-03-26
- **SIC industry:** 2834
- **HQ:** Cambridge, MA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/748592/000149315226012941/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=748592&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Ernexa Therapeutics Inc.  (ERNA, ERNAW)  (CIK 0000748592)

- UPLOAD — 2026-03-20 — /comment-letter/0000000000-26-002839

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Ernexa Therapeutics Inc.  (ERNA, ERNAW)  (CIK 0000748592) (CIK 0000748592), filed 2026-03-26, accession 0001493152-26-012941. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001493152-26-012941.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*